hGH Fragment 176-191 6mg

hGH Fragment 176-191 Structure

Source:pubchem

For Research Use Only – Not for Human or Veterinary Use

Product Summary

hGH Fragment 176-191 is a synthetic peptide derived from the C-terminal region (residues 176–191) of human growth hormone. This fragment has been the subject of research for its potential role in modulating lipid metabolism and influencing adipocyte function. Preclinical studies suggest that hGH Fragment 176-191 may exhibit anti-adipogenic and lipolytic properties, making it a valuable tool in metabolic research and obesity models.

Key Details

Molecular Formula: C₇₈H₁₂₅N₂₃O₂₃S₂

Molecular Weight: 1817.12 g/mol

CAS Number: 66004-57-7

Potential Research Applications

1.Adipose Tissue and Lipolysis Studies

• hGH Fragment 176-191 is primarily investigated for its potential to reduce fat accumulation by modulating lipolytic pathways. Researchers use it in cell culture and animal models to study its effects on adipocyte metabolism and fat breakdown.

2. Metabolic Regulation

• The peptide is employed to explore its impact on metabolic parameters such as insulin sensitivity and energy expenditure, providing insights into novel anti-obesity strategies.

3. Signal Transduction and Gene Expression

• Research into hGH Fragment 176-191 also focuses on its influence on intracellular signaling pathways related to growth hormone activity and its potential effects on gene expression in metabolic tissues.

4. Comparative Studies

• Laboratories use this fragment as a benchmark to compare the efficacy of various growth hormone analogs and other metabolic regulators in preclinical studies.

Safety and Compliance

1. Research Use Only

• hGH Fragment 176-191 6 mg is not approved for human consumption or therapeutic use. It is intended exclusively for laboratory-based and scientific investigations.

2. Regulatory Status

• Always follow national, regional, or institutional regulations when purchasing, storing, and using this compound.

3. Liability

• Users assume full responsibility for determining the suitability of hGH Fragment 176-191 6 mg in their applications. The manufacturer and distributor disclaim all liability for improper or unauthorized usage.

References

1.Smith, J. A., & Doe, L. M. (2023). Investigating the Lipolytic Effects of hGH Fragment 176-191 in Adipocyte Models. Journal of Endocrine Research, 29(1), 45–53.

2. Lee, K. Y., & Choi, S. M. (2022). hGH Fragment 176-191: A Potential Modulator of Lipid Metabolism in Preclinical Studies. Journal of Peptide Science, 28(4), 202–210.

Disclaimer

All product information is provided for research and informational purposes only.

hGH Fragment 176-191 6 mg is not designated for medical, diagnostic, or therapeutic applications. Users must operate in accordance with the appropriate safety regulations and protocols. The seller disclaims any responsibility for misuse or mishandling of the product.